Skip to content

Metastatic Breast Cancer in Brazil: Characterization of Patients and Treatments

Metastatic Breast Cancer in Brazil: Characterization of Patients and Treatments

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02662868
Enrollment
767
Registered
2016-01-26
Start date
2015-06-30
Completion date
2016-12-31
Last updated
2017-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metastatic Breast Cancer

Keywords

Breast cancer, Metastasis

Brief summary

The purpose of this study is to describe demographics and socioeconomics characteristics associated to the diagnosis of metastatic breast cancer in Brazil.

Detailed description

The primary aim of this study is to characterize patients and treatments of metastatic breast cancer in Brazil. Other specific aims are: * to describe patients demographics and socioeconomic characteristics * to describe the BC pathological characterization * to describe treatment (describe each treatment with dates start-end, cycles, dosing, sequence and line of treatment, reason for discontinuation) * to analyze patients outcome (time to progression, site of metastasis, progression free survival (PFS), overall survival (OS), skeletal related events (SRE))

Interventions

None listed

Sponsors

Novartis
CollaboratorINDUSTRY
Latin American Cooperative Oncology Group
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Women \> 18 years old * Patients diagnosed with de novo or recurrent metastatic breast cancer during the period of January to December 2012 * Any invasive breast cancer histology and subtype

Exclusion criteria

* Male breast cancer

Design outcomes

Primary

MeasureTime frame
Description of sociodemographic and socioeconomics characteristics associated to diagnostic and treatment of metastatic breast cancer in Brazil8 months

Secondary

MeasureTime frame
Description of demographic characteristics of metastatic breast cancer patients8 months
The clinical and pathological characteristics of patients with metastatic breast cancer8 months
Prior treatment for breast cancer before metastatic disease8 months
The description of the clinical outcome of the patient diagnosed with metastatic breast cancer8 months
Type of treatment after the diagnosis of metastatic breast cancer8 months

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026